Categories: NewsPharmaceutical

154,112 Orion Corporation A shares converted into B shares

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

ORION CORPORATION
STOCK EXCHANGE RELEASE – OTHER INFORMATION DISCLOSED ACCORDING TO THE RULES OF THE EXCHANGE
25 JANUARY 2023 at 9.00 EET
        

154,112 Orion Corporation A shares converted into B shares

In accordance with Section 3 of the Articles of Association of Orion Corporation, 154,112 A shares have been converted into 154,112 B shares. The conversion has been entered into the Trade Register on 25 January 2023.

The total number of shares in Orion Corporation is 141,134,278 which, after the conversion, consists of 34,032,382 A shares and 107,101,896 B shares. The number of votes of the company’s shares is after the conversion 787,749,536.

Orion Corporation

Jari Karlson

CFO

    Olli Huotari

SVP, Corporate Functions

 

                                                
Contact person:
Tuukka Hirvonen, Investor Relations, tel. +358 10 426 2721

Publisher:
Orion Corporation
Communications
Orionintie 1A, FI-02200 Espoo, Finland
www.orion.fi

Orion is a globally operating Finnish pharmaceutical company – a builder of well-being. Orion develops, manufactures and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients. The company is continuously developing new drugs and treatment methods. The core therapy areas of Orion’s pharmaceutical R&D are oncology and pain. Orion’s net sales in 2021 amounted to EUR 1,041 million and the company had about 3,350 employees at the end of the year. Orion’s A and B shares are listed on Nasdaq Helsinki.

Staff

Recent Posts

Insights From Digital Silk’s Recent Study Reveal Key Branding Priorities for U.S. Healthcare Providers

MIAMI, April 16, 2025 /PRNewswire/ -- Digital Silk, an award-winning agency focused on creating brand…

1 hour ago

Terumo Blood and Cell Technologies Names Patrick Daly as Chief Business Officer

Daly, a 30-year veteran of the healthcare industry, is the latest leadership addition to help…

1 hour ago

Cloudforce Launches nebulaONE® on Microsoft Azure: The Leading AI Gateway for Higher Education

NATIONAL HARBOR, Md., April 16, 2025 /PRNewswire/ -- Cloudforce, a Maryland-based leader in cloud and…

1 hour ago

Terumo Health Outcomes Now Offers FDA-Cleared Medis QFR® 3.0 Software for Coronary Physiology Assessment in the US

 – Innovative AI software supports hospital adoption of advanced tools to improve cath lab workflow and…

1 hour ago

THINK Surgical Announces First Use of Maxx Orthopedics’ Freedom® Total Knee implant with the TMINI® Miniature Robotic System

FREMONT, Calif., April 16, 2025 /PRNewswire/ -- THINK Surgical, Inc., an innovator in the field…

1 hour ago

Velatura Unveils Consent Manager+ with J&B Medical

First-of-its-kind AI-driven consent management platform empowers patients, clinicians, and administrators NEW YORK, April 16, 2025…

1 hour ago